BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| Dabigatran impurity 96 | Dabigatran impurity 96 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Molecular formula: C18H22N4O4. Mole weight: 358.4. |  |
| Dabigatran Impurity 97 | Dabigatran Impurity 97 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Molecular formula: C48H65N7O9. Mole weight: 884.09. | |
| Dabigatran Impurity 98 | Dabigatran Impurity 98 is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Molecular formula: C31H32N6O10. Mole weight: 648.63. | |
| Dabigatran Impurity 9 HCl | Dabigatran Impurity 9 HCl is an impurity of Dabigatran, used for efficacious therapys for medically pressing conditions, namely stroke and venous thromboembolism. Grade: > 95%. Molecular formula: C19H22ClN5O2. Mole weight: 387.87. | |
| Dabigatran impurity D | O-Butyl Dabigatran Ethyl Ester is an impurity of Dabigatran Ethyl Ester, a nonpeptide, direct thrombin inhibitor. Synonyms: O-Butyl Dabigatran Ethyl Ester; N-[[2-[[[4-[[(Butoxycarbonyl)amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinylβ-alanine Ethyl Ester. Grade: > 95%. CAS No. 1416446-43-9. Molecular formula: C32H37N7O5. Mole weight: 599.68. | |
| Dabigatran Impurity E | O-(2-Heptyl) Dabigatran Ethyl Ester is an impurity of Dabigatran Ethyl Ester, a nonpeptide, direct thrombin inhibitor. Synonyms: O-(2-Heptyl) Dabigatran Ethyl Ester; Ethyl 3-(2-(((4-(N-((Heptan-2-yloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. Grade: > 95%. CAS No. 1610758-21-8. Molecular formula: C35H43N7O5. Mole weight: 641.76. | |
| Dabigatran Impurity F | O-Octyl Dabigatrian Ethyl Ester is an impurity of Dabigatran Ethyl Ester, a nonpeptide, direct thrombin inhibitor. Synonyms: O-Octyl Dabigatran Ethyl Ester; N-[[2-[[[4-[Imino[[(octyloxy)carbonyl]amino]methyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β-Alanine Ethyl Ester. Grade: > 95%. CAS No. 211915-07-0. Molecular formula: C36H45N7O5. Mole weight: 655.79. | |
| Dabigatran Impurity H | Des-(N-2-pyridyl-β-alanine ethyl ester) Dabigatran etexilate 5-ethyl carboxylate is a derivative of Dabigatran, an oral thrombin inhibitor used to prevent venous thromboembolism. Synonyms: Des-(N-2-pyridyl-β-alanine Ethyl Ester) Dabigatran Etexilate 5-Ethyl Carboxylate; 2-[[[4-[[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazole-5-carboxylic Acid Ethyl Ester. Grade: > 95%. CAS No. 1408238-36-7. Molecular formula: C26H33N5O4. Mole weight: 479.57. | |
| Dabigatran Impurity K | An impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots. Grade: > 95%. CAS No. 211915-00-3. Molecular formula: C33H39N7O5. Mole weight: 613.72. | |
| Dabigatran Impurity M | Dabigatran Carboxamide Ethyl Ester is an impurity of Dabigatran Etexilate Mesylate which is a nonpeptide, direct thrombin inhibitor. Synonyms: Dabigatran Carboxamide Ethyl Ester. Grade: > 95%. CAS No. 1422435-41-3. Molecular formula: C27H28N6O4. Mole weight: 500.55. | |
| Dabigatran Isopropyl Ester Impurity | Dabigatran Isopropyl Ester Impurity is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. CAS No. 1610758-17-2. Molecular formula: C28H31N7O3. Mole weight: 513.6. | |
| Dabigatran Methyl Ester Impurity | Dabigatran Methyl Ester Impurity is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. CAS No. 771459-37-1. Molecular formula: C26H27N7O3. Mole weight: 485.55. | |
| Dabrafenib Mesylate | Dabrafenib, also known as GSK2118436, is an orally bioavailable inhibitor of B-raf (BRAF) protein with potential antineoplastic activity. Dabrafenib selectively binds to and inhibits the activity of B-raf, which may inhibit the proliferation of tumor cells which contain a mutated BRAF gene. B-raf belongs to the the raf/mil family of serine/threonine protein kinases and plays a role in regulating the MAP kinase/ERKs signaling pathway, which may be constitutively activated due to BRAF gene mutations. On May 29, 2013, FDA approved this drug. Synonyms: N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide methanesulfonate; Dabrafenib mesylate; GSK 2118436B; GSK2118436B; GSK-2118436B; GSK2118436 Methane sulfonate salt; Brand name: Taflinar. Grade: >98%. CAS No. 1195768-06-9. Molecular formula: C24H24F3N5O5S3. Mole weight: 615.67. | |
| Dabuzalgron | Dabuzalgron (Ro-115-1240) is an orally active and selective α-1A adrenergic receptor agonist that is administered in its hydrochloride form to control urethral smooth muscle contraction. Synonyms: Ro 115-1240; R-450. Grade: 98%. CAS No. 219311-44-1. Molecular formula: C12H16ClN3O3S. Mole weight: 317.79. | |
| dA(Bz)-3'-PS Phosphoramidite | dA(Bz)-3'-PS Phosphoramidite is a deoxyadenosine-derived phosphoramidite designed for oligonucleotide synthesis with a 3'-phosphorothioate (PS) linkage. In this modification, a non-bridging oxygen atom in the phosphate backbone is replaced by a sulfur atom, significantly improving nuclease resistance and biological stability of the oligonucleotides. The adenine base is protected with a benzoyl (Bz) group at the N6 position to prevent side reactions during synthesis while maintaining proper base-pairing properties. This phosphoramidite is particularly valuable in therapeutic oligonucleotide development, such as antisense oligonucleotides and siRNA, where enhanced stability, enzymatic resistance, and prolonged biological activity are critical for efficacy. Synonyms: 5'-DMT-dA(Bz)-3'-PS-Phosphoramidite; dA(Bz) ThioPhosphamidite; Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 3'-[S-[2-(benzoylthio)ethyl] P-1-pyrrolidinylphosphonothioite]; Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 3'-[S-[2-(benzoylthio)ethyl] 1-pyrrolidinylphosphonothioite]; S-(2-(((((2R,3S,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)tetrahydrofuran-3-yl)oxy)(pyrrolidin-1-yl)phosphaneyl)thio)ethyl) benzothioate. Grade: ≥90%. CAS No. 178272-29-2. Molecular formula: C51H51N6O7PS2. Mole weight: 955.09. | |
| dA(Bz)-PACE Phosphoramidite | dA-PACE Phosphoramidite is a crucial reagent utilized in the development of oligonucleotide therapeutics for treating various genetic disorders such as cystic fibrosis and Huntington's disease. The unique PACE (phosphoramidite conjugated to aminohexylCE) modification improves the pharmacokinetic properties of the resulting oligonucleotide drugs, allowing for enhanced cellular uptake and longer half-life in the body. Synonyms: dA-PACE Phosphoramidite; 5'-Dimethoxytrityl-N-benzoyl-2'-deoxyAdenosine, 3'-O-(N,N-diisopropylamino)-phosphinyl-1,1-dimethyl-2-cyanoethyl acetate; Adenosine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 3'-[P-[2-(2-cyano-1,1-dimethylethoxy)-2-oxoethyl]-N,N-bis(1-methylethyl)phosphonamidite]; DNA A(Bz) PACE amidite. Grade: ≥95%. CAS No. 411234-24-7. Molecular formula: C51H58N7O8P. Mole weight: 928.02. | |
| DAC-2-25 | DAC-2-25 is a modulator of Hydra head regeneration. Grade: >98%. CAS No. 1675245-09-6. Molecular formula: C14H16N2O. Mole weight: 228.29. | |
| Dacarbazine | Dacarbazine is an antineoplastic chemotherapy drug used in the treatment of various cancers.Dacarbazine is a member of the class of alkylating agents, which destroy cancer cells by adding an alkyl group (CnH2n+1) to its DNA. Uses: Anti-tumor. Synonyms: DTIC-Dome. Grade: >98%. CAS No. 4342-3-4. Molecular formula: C6H10N6O. Mole weight: 182.18. | |
| Dacarbazine Impurity A | 2-Azahypoxanthine, is an impurity of Dacarbazine, which is used as an antineoplastic for treatment of various cancers such as, malignant melanoma and sarcomas. Synonyms: 2-Azahypoxanthine; 3,7-Dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one; 1,5-Dihydro-4H-Imidazo[4,5-d]-1,2,3-triazin-4-one; 3,7-Dihydro-4H-imidazo[4,5-d]-v-triazin-4-one. Grade: > 95%. CAS No. 4656-86-4. Molecular formula: C4H3N5O. Mole weight: 137.1. | |
| Dacarbazine USP Related Compound B | An impurity of Dacarbazine, which is used as an antineoplastic for treatment of various cancers such as, malignant melanoma and sarcomas. Synonyms: Dacarbazine Impurity A monohydrate; Dacarbazine EP Impurity A monohydrate; Dacarbazine Related Compound B; USP Dacarbazine Related Compound B; 4H-Imidazo[4,5-d]-1,2,3-triazin-4-one, 3,7-dihydro-, hydrate (1:1); 7H-Imidazo[4,5-d]-1,2,3-triazin-4-ol, monohydrate; 3,7-Dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one monohydrate; 1,5-Dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one monohydrate; 2-Azahypoxanthine monohydrate; Azahypoxanthine monohydrate; NSC 22419 monohydrate. Grade: ≥95%. CAS No. 7151-3-3. Molecular formula: C4H5N5O2. Mole weight: 155.12. | |
| Dacetuzumab | Dacetuzumab is an anti-CD40 monoclonal antibody that has been developed for the treatment of relapsed diffuse large B-cell lymphoma (DLBCL). Synonyms: SGN-40; SGN 40; SGN40; huS2C6. CAS No. 880486-59-9. | |
| Dacinostat | Dacinostat, also known as LAQ824, is a hydroxamate histone deacetylase inhibitor with potential anticancer activity. LAQ824 sensitized nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation. LAQ824 reduced clonogenic survival of the H23 and H460 cell lines five-fold compared with controls and four-fold compared with either agent alone (P<0.001). In phase I trials, LAQ824 was well tolerated at doses that induced accumulation of histone acetylation, with higher doses inducing changes consistent with HSP90 inhibition. Synonyms: NVP-LAQ824; NVP LAQ824; LAQ-824; LAQ824; LAQ 824; Dacinostat. CAS No. 404951-53-7. Molecular formula: C22H25N3O3. Mole weight: 379.46. | |
| Daclatasvir | Daclatasvir, inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir; BMS-790052; BMS 790052; BMS790052; EBP-883; EBP 883; EBP883; trade name Daklinza. Grade: 0.98. CAS No. 1009119-64-5. Molecular formula: C40H50N8O6. Mole weight: 738.89. | |
| Daclatasvir-d16 | Daclatasvir-d16 is a labelled Daclatasvir which inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: BMS-790052-d16; EBP 883-d16. Grade: > 95%. Molecular formula: C40H34D16N8O6. Mole weight: 754.97. | |
| Daclatasvir dihydrochloride | Daclatasvir is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype 2a infectious virus in cell culture. Synonyms: Methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate dihydrochloride; Daclatasvir; BMS790052; BMS 790052; BMS-790052; EBP883; EBP 883; EBP-883; Daklinza. Grade: >98%. CAS No. 1009119-65-6. Molecular formula: C40H50N8O6ยท2HCl. Mole weight: 811.8. | |
| Daclatasvir Impurity 6 | Daclatasvir SRRS Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir SRRS Isomer; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2R)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester. Grade: > 95%. CAS No. 1009117-26-3. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclatasvir RSSR Isomer | Daclatasvir RSSR Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir Impurity 4; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1R)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester. Grade: > 95%. CAS No. 1009107-27-0. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclatasvir RSSS Isomer | Daclatasvir RSSS Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-2,1-pyrrolidinediyl[1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid C,C'-dimethyl ester stereoisomer. CAS No. 1417333-83-5. Molecular formula: C40H50N8O6. Mole weight: 738.88. | |
| Daclizumab | Daclizumab is a humanized monoclonal antibody of the human IgG1 isotype that binds specifically to the Tac epitope on the α-subunit (CD25) of the IL-2R. Synonyms: Zenapax; Ro 24-7375. CAS No. 152923-56-3. Molecular formula: C6332H9808N1678O1989S42. Mole weight: 142612.1. | |
| Dacomitinib | Dacomitinib, aslo known as PF-299 and PF-00299804; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types. Synonyms: dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; PF 299; PF299. CAS No. 1110813-31-4. Molecular formula: C24H25ClFN5O2. Mole weight: 469.945. | |
| Dacomitinib Hydrate | Dacomitinib is a second-generation small molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) tyrosine kinase family (ErbB family) with potential anti-tumor activity. Uses: Tyrosine kinase inhibitors. Synonyms: PF-00299804; PF00299804; PF 00299804; PF299804. CAS No. 1042385-75-0. Molecular formula: C24H25ClFN5O2.H2O. Mole weight: 487.96. | |
| Dacomitinib Impurity 2F3L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3F4L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3F4LAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H12ClFN4O. Mole weight: 318.73. | |
| Dacomitinib Impurity 3F4LXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H10ClFN4O3. Mole weight: 348.72. | |
| Dacomitinib Impurity BDS | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C19H16ClFN4O2. Mole weight: 386.81. | |
| Dacomitinib Impurity C | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. CAS No. 869199-69-9. Molecular formula: C25H27ClFN5O2. Mole weight: 483.97. | |
| Dacomitinib Impurity D | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. CAS No. 869199-67-7. Molecular formula: C26H29ClFN5O2. Mole weight: 497.99. | |
| Dacomitinib Impurity DF | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H26FN5O2. Mole weight: 435.50. | |
| Dacomitinib Impurity DFAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Synonyms: N4-(4-Fluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity); N4-(4-FLUOROPHENYL)-7-METHOXYQUINAZOLINE-4,6-DIAMINE; Dacomitinib Impurity DFAJ; CS-0255390; F83326. Grade: ≥95%. CAS No. 1562180-31-7. Molecular formula: C15H13FN4O. Mole weight: 284.29. | |
| Dacomitinib Impurity DFXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. CAS No. 2185841-22-7. Molecular formula: C15H11FN4O3. Mole weight: 314.27. | |
| Dacomitinib Impurity E | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H27ClFN5O3. Mole weight: 487.96. | |
| Dacomitinib Impurity SF | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H25F2N5O2. Mole weight: 453.49. | |
| Dacomitinib Impurity SFAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Synonyms: Dacomitinib Impurity SFAJ; CS-0255393; F83329; N4-(3,4-Difluorophenyl)-7-methoxyquinazoline-4,6-diamine; N4-(3,4-DIFLUOROPHENYL)-7-METHOXY-QUINAZOLINE-4,6-DIAMINE; N4-(3,4-Difluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity). Grade: ≥95%. CAS No. 2117703-26-9. Molecular formula: C15H12F2N4O. Mole weight: 302.28. | |
| Dacomitinib Impurity SFXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. CAS No. 2119689-75-5. Molecular formula: C15H10F2N4O3. Mole weight: 332.26. | |
| Dacomitinib Impurity SL | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H25Cl2N5O2. Mole weight: 486.40. | |
| Dacomitinib Impurity SLAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H12Cl2N4O. Mole weight: 335.19. | |
| Dacomitinib Impurity SLXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H10Cl2N4O3. Mole weight: 365.17. | |
| Dacomitinib Impurity WZYG | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity WZYGAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H12ClFN4O. Mole weight: 318.74. | |
| Dacomitinib Impurity WZYGXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grade: ≥95%. Molecular formula: C15H10ClFN4O3. Mole weight: 348.72. | |
| Dactolisib | Dactolisib, also known as BEZ235, is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. BEZ235 specifically inhibits PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway, which may trigger the translocation of cytosolic Bax to the mitochondrial outer membrane, increasing mitochondrial membrane permeability. Synonyms: BEZ235; BEZ-235; BEZ 235; NVPBEZ235; NVP-BEZ235; NVP-BEZ-235; NVP-BEZ 235; Dactolisib. Grade: 0.98. CAS No. 915019-65-7. Molecular formula: C30H23N5O. Mole weight: 469.548. | |
| DAD | DAD is a type of ion channel blocker. It blocks voltage-gated potassium channels. DAD has the potential for restoring visual function. Molecular formula: C26H40N6O. Mole weight: 452.64. | |
| DAD dichloride | DAD dichloride is a type of ion channel blocker. It blocks voltage-gated potassium channels. DAD dichloride has the potential for restoring visual function. Molecular formula: C26H42Cl2N6O. Mole weight: 525.56. | |
| dADPαS | dADPαS is an extraordinary compound, deftly inhibiting key enzymes responsible for DNA replication and repair processes. dADPαS can used to present a promising avenue for suppressing tumor progression. Synonyms: 2'-Deoxyadenosine-5'-(α-thio)-diphosphate, Triethylammonium salt. Grade: ≥ 95% by HPLC. Molecular formula: C10H15N5O8P2S (free acid). Mole weight: 427.26 (free acid). | |
| Dafadine-A | Dafadine-A, the first identified chemical inhibitor of DAF-9, could restrain the dauer formation, developmental timing and longevity in the nematodeCaenorhabditis elegans. Uses: Dafadine-a could restrain the dauer formation, developmental timing and longevity in the nematodecaenorhabditis elegans. Synonyms: Dafadine-A; CHEBI:88327; 1065506-69-5; Ambcb24199950; MLS001090772; CHEMBL1585869. Grade: 98%. CAS No. 1065506-69-5. Molecular formula: C23H25N3O3. Mole weight: 391.46. | |
| Daglutril | Daglutril is a dual endothelin converting enzyme (ECE)/neutral endopeptidase (NEP) inhibitor used for the treatment of hypertension and heart failure andpulmonary. It reduces proteinuria and urinary albumin excretion in diabetic rats, and inhibits systemic conversion of big endothelin-1 in humans. Synonyms: SLV-306; SLV306; SLV 306; 2-[(3S)-3-[[1-[(2R)-2-ethoxycarbonyl-4-phenylbutyl]cyclopentanecarbonyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid. Grade: 99%. CAS No. 182821-27-8. Molecular formula: C31H38N2O6. Mole weight: 534.64. | |
| Dagrocorat hydrochloride | Dagrocorat hydrochloride is an orally active, selective and high-affinity glucocorticoid receptor partial agonist, as well as a time-dependent reversible inhibitor of CYP3A (IC50 = 1.3 μM in human liver microsomes) and CYP2D6 (Ki = 0.57 μM in human liver microsomes). It can be used in the study of rheumatoid arthritis. Synonyms: PF-00251802 hydrochloride; 2-Phenanthrenecarboxamide, 4b,5,6,7,8,8a,9,10-octahydro-7-hydroxy-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(trifluoromethyl)-, hydrochloride (1:1), (4bS,7R,8aR)-; (4bS,7R,8aR)-4b-Benzyl-7-hydroxy-N-(2-methyl-3-pyridinyl)-7-(trifluoromethyl)-4b,5,6,7,8,8a,9,10-octahydro-2-phenanthrenecarboxamide hydrochloride (1:1). CAS No. 1044535-61-6. Molecular formula: C29H30ClF3N2O2. Mole weight: 531.01. | |
| dA-H-Phosphonate, TEA Salt | dA-H-Phosphonate, TEA Salt is a compound of biochemical importance in the pharmaceutical industry, owing to its utilization as a phosphonate ester in synthesizing drugs. Furthermore, it finds application as a versatile research reagent for investigating several diseases, ranging from cancer, HIV, to Alzheimer's. The unique chemical characteristics of this compound make it an efficient inhibitor of enzymes and cellular processes, thereby aiding researchers in better comprehending the intricacies of biological pathways. Synonyms: 5'-Dimethoxytrityl-N-benzoyl-2'-deoxyAdenosine, 3'-H-phosphonate, TEA salt. Molecular formula: C44H51N6O8P. Mole weight: 822.9. | |
| Daidzein 7-b-D-glucuronide 4-sulfate disodium salt | Daidzein 7-b-D-glucuronide 4-sulfate disodium salt, a remarkable biomedical compound, emerges as a potent therapeutic intervention targeting diverse ailments. Standout among its commendable attributes lies in its unparalleled efficacy against malignant neoplasms, predominantly those affecting the mammary and prostatic glands. Delighting the medical community, this product manifests antioxidant, anti-inflammatory, and immune-modulatory properties. Synonyms: 4-Oxo-3-[4-(sulfooxy)phenyl]-4H-1-benzopyran-7-yl b-D-glucopyranosiduronic acid sodium salt; β-D-Glucopyranosiduronic acid, 4-oxo-3-[4-(sulfooxy)phenyl]-4H-1-benzopyran-7-yl, sodium salt (1:2); Daidzein 7-glucuronide-4'-sulfate disodium salt. CAS No. 1041134-19-3. Molecular formula: C21H16Na2O13S. Mole weight: 554.39. | |
| Daidzein 7-O-b-D-glucuronide potassium salt | Daidzein 7-O-b-D-glucuronide potassium salt is a heralded pharmaceutical compound exhibiting multifaceted attributes encompassing potential antioxidant prowess alongside unparalleled anti-inflammatory properties. Synonyms: 3-(4-Hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl b-D-Glucopyranosiduronic acid potassium salt. Molecular formula: C21H18O10. Mole weight: 430.36. | |
| Daidzein-[d3] 7-O-b-D-glucopyranoside | Daidzein-D3-7-O-b-D-glucopyranoside, a cutting-edge compound extensively employed in biomedicine, showcases unparalleled efficacy in the management of a multitude of ailments, encompassing malignancies, cardiovascular dysfunctions, and skeletal fragility. It manifests remarkable antioxidative and anti-inflammatory attributes, bestowing upon it a pivotal role in the realm of pharmaceutical investigation and medicinal breakthroughs. As an invaluable asset, Daidzein-D3-7-O-b-D-glucopyranoside substantiates comprehension and mitigation of said pathological states, thereby fostering pioneering strides in the arena of biomedical scrutiny and therapeutic interventions. Synonyms: 4H-1-Benzopyran-4-one-8-d, 7-(β-D-glucopyranosyloxy)-3-(4-hydroxyphenyl-3,5-d2)-; Daidzein-D3-7-O-b-D-glucopyranoside; 7-(β-D-Glucopyranosyloxy)-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one-d3; Daidzin-d3; 7,4'-Dihydroxyisoflavone 7-glucoside-d3; Daidzein 7-glucoside-d3; Daidzein 7-O-glucoside-d3; Daidzine-d3; Daidzoside-d3. CAS No. 220930-97-2. Molecular formula: C21H17D3O9. Mole weight: 419.39. | |
| D-Ala(18)-Semaglutide | D-Ala(18)-Semaglutide is an impurity of Semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. Synonyms: [D-Ala18]-Semaglutide; (3S,9S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,45S,48R,51S,54S,81R)-54-(((6S,12S,15S,18S,21S,24S,27S,30S,33S)-21-((1H-indol-3-yl)methyl)-1-amino-30-benzyl-27-((S)-sec-butyl)-35-carboxy-6-((carboxymethyl)carbamoyl)-12-(3-guanidinopropyl)-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29,32-nonaoxo-2,7,10,13,16,19,22,25,28,31-decaazapentatriacontan-33-yl)carbamoyl)-3-(2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)-2-methylpropanamido)-45-(3-amino-3-oxopropyl)-12-benzyl-39-(2-carboxyethyl)-21-(carboxymethyl)-33-(4-hydroxybenzyl)-9,15-bis((R)-1-hydroxyethyl)-18,27,30-tris(hydroxymethyl)-36-isobutyl-24-isopropyl-48,51-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,60,69,78,83-henicosaoxo-62,65,71,74-tetraoxa-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,59,68,77,82-henicosaazanonanonacontane-1,81,99-tricarboxylic acid. Grade: 95%. Molecular formula: C187H291N45O59. Mole weight: 4113.64. | |
| D-Ala(19)-Semaglutide | D-Ala(19)-Semaglutide is an impurity of Semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. Synonyms: D-Ala-19-Semaglutide; (3S,9S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,45S,48S,51R,54S,81R)-54-(((6S,12S,15S,18S,21S,24S,27S,30S,33S)-21-((1H-indol-3-yl)methyl)-1-amino-30-benzyl-27-((S)-sec-butyl)-35-carboxy-6-((carboxymethyl)carbamoyl)-12-(3-guanidinopropyl)-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29,32-nonaoxo-2,7,10,13,16,19,22,25,28,31-decaazapentatriacontan-33-yl)carbamoyl)-3-(2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)-2-methylpropanamido)-45-(3-amino-3-oxopropyl)-12-benzyl-39-(2-carboxyethyl)-21-(carboxymethyl)-33-(4-hydroxybenzyl)-9,15-bis((R)-1-hydroxyethyl)-18,27,30-tris(hydroxymethyl)-36-isobutyl-24-isopropyl-48,51-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,60,69,78,83-henicosaoxo-62,65,71,74-tetraoxa-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,59,68,77,82-henicosaazanonanonacontane-1,81,99-tricarboxylic acid. Grade: 95%. Molecular formula: C187H291N45O59. Mole weight: 4113.64. | |
| D-Ala(24)-Semaglutide | D-Ala(24)-Semaglutide is an impurity of Semaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes. Synonyms: D-Ala-24-Semaglutide; (3S,9S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,45S,48S,51S,54S,81R)-54-(((6S,12S,15S,18S,21S,24R,27S,30S,33S)-21-((1H-indol-3-yl)methyl)-1-amino-30-benzyl-27-((S)-sec-butyl)-35-carboxy-6-((carboxymethyl)carbamoyl)-12-(3-guanidinopropyl)-1-imino-18-isobutyl-15-isopropyl-24-methyl-8,11,14,17,20,23,26,29,32-nonaoxo-2,7,10,13,16,19,22,25,28,31-decaazapentatriacontan-33-yl)carbamoyl)-3-(2-((S)-2-amino-3-(1H-imidazol-4-yl)propanamido)-2-methylpropanamido)-45-(3-amino-3-oxopropyl)-12-benzyl-39-(2-carboxyethyl)-21-(carboxymethyl)-33-(4-hydroxybenzyl)-9,15-bis((R)-1-hydroxyethyl)-18,27,30-tris(hydroxymethyl)-36-isobutyl-24-isopropyl-48,51-dimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,60,69,78,83-henicosaoxo-62,65,71,74-tetraoxa-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,59,68,77,82-henicosaazanonanonacontane-1,81,99-tricarboxylic acid. Grade: 95%. Molecular formula: C187H291N45O59. Mole weight: 4113.64. | |
| D-Alanine-1-13C,15N | D-Alanine-1-13C,15N is a labelled D-alanine. Alanine is one of the non-essential amino acids for humans. Alanine is the key compound in glucose-alanine cycle. Grade: 95% by HPLC; 99% atom 13C, 98% atom 15N. Molecular formula: CH3CH(15NH2)[13C]O2H. Mole weight: 91.08. | |
| D-Alanine-2-13C | D-Alanine-2-13C is a labelled D-alanine. Alanine is one of the non-essential amino acids for humans. Alanine is the key compound in glucose-alanine cycle. Grade: 95% by HPLC; 99% atom 13C. Molecular formula: CH3[13C]H(NH2)CO2H. Mole weight: 90.09. | |
| D-Alanine-2,3,3,3-d4 | D-Alanine-2,3,3,3-d4 is a labelled D-Alanine. Alanine is one of the non-essential amino acids for humans. Alanine is the key compound in glucose-alanine cycle. Synonyms: (R)-2-Aminopropionic Acid-d4; D-α-Alanine-d4; H-D-Ala-OH-d4. Grade: 95% by HPLC; 98% atom D. CAS No. 1202063-27-1. Molecular formula: CD3CD(NH2)COOH. Mole weight: 93.12. | |
| D-Alanine-2,3,3,3-d4-N-FMOC | D-Alanine-2,3,3,3-d4-N-FMOC is a labelled D-Alanine-N-FMOC. Alanine is one of the non-essential amino acids for humans. Alanine is the key compound in glucose-alanine cycle. Synonyms: FMOC-D-Alanine-d4; FMOC-D-Ala-OH-d4. Grade: 95% by HPLC; 98% atom D. Molecular formula: CD3CD(NH-FMOC)COOH. Mole weight: 315.36. | |
| D-Alanine-2,3,3,3-d4-N-t-BOC | D-Alanine-2,3,3,3-d4-N-t-BOC is a labelled D-Alanine-N-t-BOC. Alanine is one of the non-essential amino acids for humans. Alanine is the key compound in glucose-alanine cycle. Synonyms: BOC-D-Alanine-d4; BOC-D-Ala-OH-d4. Grade: 95% by HPLC; 98% atom D. Molecular formula: CD3CD(NH-t-BOC)COOH. Mole weight: 193.23. | |
Our database is helping our users find suppliers everyday.
